EP0458903A4 - Soluble analogs of thrombomodulin - Google Patents
Soluble analogs of thrombomodulinInfo
- Publication number
- EP0458903A4 EP0458903A4 EP19900904135 EP90904135A EP0458903A4 EP 0458903 A4 EP0458903 A4 EP 0458903A4 EP 19900904135 EP19900904135 EP 19900904135 EP 90904135 A EP90904135 A EP 90904135A EP 0458903 A4 EP0458903 A4 EP 0458903A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- thrombomodulin
- soluble analogs
- analogs
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000012607 Thrombomodulin Human genes 0.000 title 1
- 108010079274 Thrombomodulin Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/7455—Thrombomodulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31214189A | 1989-02-17 | 1989-02-17 | |
| US312141 | 1989-02-17 | ||
| US34537289A | 1989-04-28 | 1989-04-28 | |
| US345372 | 1989-04-28 | ||
| US40694189A | 1989-09-13 | 1989-09-13 | |
| US406941 | 1989-09-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0458903A1 EP0458903A1 (de) | 1991-12-04 |
| EP0458903A4 true EP0458903A4 (en) | 1992-06-17 |
Family
ID=27405562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19900904135 Withdrawn EP0458903A4 (en) | 1989-02-17 | 1990-02-16 | Soluble analogs of thrombomodulin |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0458903A4 (de) |
| JP (1) | JPH04505554A (de) |
| KR (1) | KR920701459A (de) |
| AU (1) | AU646633B2 (de) |
| CA (1) | CA2046906A1 (de) |
| WO (1) | WO1990010081A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063763A (en) * | 1989-04-28 | 2000-05-16 | Schering Aktiengesellschaft | Protease-resistant thrombomodulin analogs |
| GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
| DK0544826T3 (da) * | 1990-08-15 | 2002-04-22 | Paion Gmbh | Overlegne trombomodulinanaloger til farmaceutisk anvendelse |
| EP0641215B1 (de) * | 1992-02-05 | 2004-04-21 | Paion GmbH | Protease-resistente analoge des thrombomodulin |
| AU4533093A (en) * | 1992-06-10 | 1994-01-04 | Michael John Morser | Mutants of the epidermal growth factor domains of human thrombomodulin |
| US5585095A (en) * | 1993-09-14 | 1996-12-17 | Regents Of The University Of Minnesota | Method to enhance thrombomodulin APC generation using cationic proteins |
| US5830448A (en) * | 1994-06-16 | 1998-11-03 | Genentech, Inc. | Compositions and methods for the treatment of tumors |
| US7579000B2 (en) | 2002-05-01 | 2009-08-25 | Bayer Schering Pharma Ag | Tissue factor targeted antibodies as anticoagulants |
| CN100412090C (zh) * | 2002-05-01 | 2008-08-20 | 舍林股份公司 | 作为抗凝剂的新的靶向组织因子的血栓调节蛋白融合蛋白 |
| CA2609262A1 (en) | 2005-06-03 | 2006-12-07 | Mochida Pharmaceutical Co., Ltd. | Anti-cd14 antibody fusion protein |
| BR112013002739A2 (pt) * | 2010-08-05 | 2019-09-24 | Council Scient Ind Res | constructos de proteínas de fusão que possuem propriedades trombolíticas e anticoagulantes |
| CN119798451B (zh) * | 2025-01-06 | 2025-08-12 | 印月生物技术(杭州)有限公司 | 抗人凝血酶调节蛋白的单克隆抗体及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4849403A (en) * | 1985-05-29 | 1989-07-18 | Pentapharm Ag | Protein C activator, methods of preparation and use thereof |
| JPH0689014B2 (ja) * | 1986-01-21 | 1994-11-09 | 興和株式会社 | トロンビン結合性物質およびその製法 |
| US4912207A (en) * | 1987-05-06 | 1990-03-27 | Washington University | DNA clone of human thrombomodulin and portions thereof |
| DK299087D0 (da) * | 1987-06-12 | 1987-06-12 | Novo Industri As | Proteins and derivatives thereof |
| US5256770A (en) * | 1990-04-09 | 1993-10-26 | Schering Ag | Oxidation resistant thrombomodulin analogs |
| CA2022713A1 (en) * | 1989-08-11 | 1991-02-12 | Nils U. Bang | Human thrombomodulin derivatives |
-
1990
- 1990-02-16 AU AU51917/90A patent/AU646633B2/en not_active Ceased
- 1990-02-16 JP JP2504399A patent/JPH04505554A/ja active Pending
- 1990-02-16 KR KR1019910700941A patent/KR920701459A/ko not_active Withdrawn
- 1990-02-16 CA CA002046906A patent/CA2046906A1/en not_active Abandoned
- 1990-02-16 EP EP19900904135 patent/EP0458903A4/en not_active Withdrawn
- 1990-02-16 WO PCT/US1990/000955 patent/WO1990010081A1/en not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| No further relevant documents have been disclosed. * |
| See also references of WO9010081A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR920701459A (ko) | 1992-08-11 |
| WO1990010081A1 (en) | 1990-09-07 |
| AU5191790A (en) | 1990-09-26 |
| EP0458903A1 (de) | 1991-12-04 |
| JPH04505554A (ja) | 1992-10-01 |
| AU646633B2 (en) | 1994-03-03 |
| CA2046906A1 (en) | 1990-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB8909571D0 (en) | Novel cyclopentano-vitamin d analogs | |
| EP0432600A3 (en) | Derivatives of 2-iminopyridine | |
| AU105885S (en) | Flask | |
| GB8724553D0 (en) | Substituted 2-benzylmercapto-imidazoles & analogs | |
| IL96306A0 (en) | Preparation of deoxyfluoronucleosides | |
| HU895848D0 (en) | Process for the preparation of fluoxethyne analogs | |
| ZA874863B (en) | Novel 18-phenyloestrane derivatives | |
| EP0458903A4 (en) | Soluble analogs of thrombomodulin | |
| EP0405560A3 (en) | Preparation of tertiary-hydrocarbylsilyl compounds | |
| GB8727068D0 (en) | Pattern preparation | |
| GB8713987D0 (en) | Medicarpin derivatives & analogs | |
| PL286613A1 (en) | Method of obraining novel aminopropanel derivatives | |
| JPS6490141A (en) | Perfluorobutyl derivative compound | |
| YU146288A (en) | Derivatives of benzimidazole-2-il-pyridinium | |
| YU53490A (en) | Derivatives of tetrahydronaphtaline | |
| EP0415320A3 (en) | Selective production of threo-epoxy compounds | |
| PL288672A1 (en) | Method of obtaining novel derivatives of 2-hydroxy-3-thienyloxypropylamine compounds | |
| ZA897150B (en) | Crf analogs | |
| GB2205313B (en) | Preparation of trifluoromethyltoluene from halomethylbenzotrifluoride | |
| JPS6490139A (en) | Synthesis of cis-9-tricocene | |
| IL95825A0 (en) | Production of tetrathiocarbonates | |
| IL95024A0 (en) | Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates | |
| GR910300027T1 (en) | Production of alpha-chloro-alpha-oximino-4-hydroxy-acetophenone | |
| EP0262852A3 (en) | Prodrugs of antihypercholoesterolemic compounds | |
| GB8918394D0 (en) | Preparation of polyhemiacetals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19910726 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19920428 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19940705 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19941116 |